Literature DB >> 15874875

Expression of epidermal growth factor receptor in cervical tissue and serum in patients with cervical neoplasia.

Seung Cheol Kim1, H-M Park, S-N Lee, W-S Han.   

Abstract

OBJECTIVE: We hypothesized that there may be a relationship between epidermal growth factor receptor (EGFR) expression in cervical tissue and serum in patients with cervical neoplasia.
MATERIALS AND METHODS: The expression of EGFR was measured in cervical tissues from 23 cervical intraepithelial neoplasia patients and 16 cervical carcinoma patients using immunohistochemical staining and the level of serum EGFR extracellular domain was measured in serum from 17 cervical intraepithelial neoplasia patients and 14 cervical carcinoma patients using enzyme-linked immunosorbent assay.
RESULTS: The expression of EGFR was significantly increased as normal cervical tissue progressed to cervical intra-epithelial neoplasia then to cervical carcinoma (p = .009). The mean level of serum EGFR according to the intensity of immunohistochemical staining in negative, weakly positive, positive, and strongly positive staining was 19.36 +/- 3.12 fmol/mL, 20.99 +/- 3.59 fmol/mL, 29.08 +/- 16.86 fmol/mL, and 24.34 +/- 10.35 fmol/mL, respectively (p = .450).
CONCLUSIONS: We believe that the level of serum EGFR may have a similar role as tumor markers such as the EGFR expression in cervical neoplastic tissue.

Entities:  

Year:  2004        PMID: 15874875     DOI: 10.1097/00128360-200410000-00006

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  2 in total

1.  Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer.

Authors:  Duanduan Ma; Raymond L Hovey; Zhengyan Zhang; Samantha Fye; Phyllis C Huettner; Ingrid B Borecki; Janet S Rader
Journal:  Gynecol Oncol       Date:  2013-08-06       Impact factor: 5.482

2.  Detection of a soluble form of CD109 in serum of CD109 transgenic and tumor xenografted mice.

Authors:  Hiroki Sakakura; Yoshiki Murakumo; Shinji Mii; Sumitaka Hagiwara; Takuya Kato; Masato Asai; Akiyoshi Hoshino; Noriyuki Yamamoto; Sayaka Sobue; Masatoshi Ichihara; Minoru Ueda; Masahide Takahashi
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.